|
Effects of interruptions of radiotherapy on outcomes of patients with prostate cancer. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - New Century Health |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - GlaxoSmithKline; Johnson & Johnson |
Consulting or Advisory Role - Myriad Genetics |
Speakers' Bureau - Janssen Oncology |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |